# Metoprolol in Acute Myocardial Infarction. A PK/PD Study

> **NCT01523054** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 27 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Metoprolol- Toprol XL
- **DRUG:** Metoprolol- Lopressor

## Key facts

- **NCT ID:** NCT01523054
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** 2002-04
- **Final completion:** 2002-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2012-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523054, "Metoprolol in Acute Myocardial Infarction. A PK/PD Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01523054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
